Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04627376

Multimodal Program for Cancer Related Cachexia Prevention

Led by Cyprus University of Technology · Updated on 2022-09-02

60

Participants Needed

1

Research Sites

296 weeks

Total Duration

On this page

Sponsors

C

Cyprus University of Technology

Lead Sponsor

G

German Oncology Center, Cyprus

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to evaluate the effectiveness of a multifactorial education and support program for the prevention of cancer-related cachexia syndrome, for patients and their family caregivers during anti-cancer treatment.

CONDITIONS

Official Title

Multimodal Program for Cancer Related Cachexia Prevention

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years old or older
  • Diagnosed with solid tumor (stomach, colorectal, pancreas, breast, lung)
  • Receiving chemotherapy, immunotherapy, hormone therapy, or targeted therapy
  • Normal or pre-cachectic stage as defined by guidelines
  • Able to read and understand Greek or English
Not Eligible

You will not qualify if you...

  • Diagnosed with hematologic tumors
  • Receiving parenteral nutrition
  • ECOG performance status greater than 2 or Karnofsky performance status less than 60%
  • Unable to nominate a family caregiver
  • In cachexia or refractory cachexia stage as defined by guidelines, including:
    • More than 5% weight loss over past 6 months without simple starvation
    • BMI less than 20 with weight loss over 2%
    • Sarcopenia based on appendicular skeletal muscle index and weight loss over 2%
  • Using complementary therapies such as acupuncture

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

German Oncology Centre

Limassol, Cyprus, 4065

Actively Recruiting

Loading map...

Research Team

A

Andreas Charalambous, PhD

CONTACT

C

Constantina Cloconi, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here